Biotech

All Articles

ProKidney stops period 3 test certainly not required for tissue treatment confirmation

.ProKidney has actually quit one of a pair of period 3 tests for its own tissue therapy for kidney h...

Vaxcyte climbs on 'stunning' 31-valent PCV win versus Pfizer

.Vaxcyte unveiled what professionals referred to as "magnificent" phase 1/2 records for its own 31-v...

Recursion's mind health condition test reveals scant evidence of efficiency

.Recursion has actually stumbled through an early test of its own tech-enabled approach to drug reve...

Acepodia, Pfizer click together for chemistry-based tissue treatment

.Call it a situation of really good chemical make up: Acepodia, a biotech based upon Nobel Prize-win...

Praxis epilepsy medication lowers confiscations in stage 2 trial

.Practice Preciseness Medicines has actually scored one more midphase win in epilepsy this year, wit...

Three directors resign as Dyne posts mixed records for DMD prospect

.After leaving a professional hold many years back, Dyne Therapy has uncovered brand new stage 1/2 i...

Arrowhead fires off phase 3 records in uncommon metabolic disease before market clash with Ionis

.Arrowhead Pharmaceuticals has shown its hand in front of a possible showdown along with Ionis, post...

Pfizer, Valneva present lyme disease go helpful for second enhancer

.Pfizer and Valneva may possess concerning two additional years to wait before they make the first c...

Fierce Biotech Editor-in-Chief Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Permit's dive into a discussion with Ayla Ellison, Brutal Biotech Editor-in-Chief and Michelle Benz...

New information show how Bayer's asundexian fell short to prevent strokes

.Bayer put on hold the phase 3 test for its own variable XIa prevention asundexian behind time in 20...